Transcranial direct current stimulation (tDCS) is a form of non-invasive brain stimulation that safely modulates brain activity. Several studies have shown that tDCS of the motor cortex facilitates motor learning and plasticity but there is little information on the underlying mechanisms. This analysis of metabolite changes in response to 1mA tDCS using typical PRESS and MEGA-PRESS is important in developing a complete understanding of the effects of stimulation. In this pediatric study, we did not detect the same GABA and glutamate changes in response to tDCS that have been seen in the adult literature.
Transcranial direct current stimulation (tDCS) is a form of non-invasive brain stimulation in which a weak electrical current is passed between two electrodes placed on the scalp. This causes a shift in cortical excitability, for example when the primary motor cortex (M1) is targeted with the anode, cortical excitability increases1. Previous research has shown that tDCS can improve symptoms in several neurological disorder including migraine, depression, stroke, Parkinson’s as well as pain disorders with minimal side effects2. TDCS appears to enhance motor learning in pediatric populations and increases in motor skills were retained at 6 weeks after the tDCS intervention3,4. Such studies support the use of tDCS as a therapeutic tool in children but the biological mechanisms remain unknown. Adult studies show motor learning to be associated with a decrease in GABA and an increase in glutamate in M15. Pharmacological studies suggest that cortical changes induced by tDCS are associated with long-term potentiation that is mediated by glutamatergic and GABAergic neurons6. With anodal tDCS, the tissue targeted by stimulation shows GABA decreases and glutamate increases 7-10. These metabolite changes have been associated with changes in task performance7. It is unknown if these findings translate to a pediatric population and how long changes in metabolites persist.
Twenty-four typically developing, right-handed children (age 12 – 18 years) participated in five consecutive days of tDCS intervention targeting the right M1 while training in a motor task (Purdue Pegboard Task) with their left hand (Fig 1A). Participants were randomly assigned to one of three experimental groups (Fig 1B):
Spectroscopy data was collected on a 3T GE MRI scanner at baseline, after the 5 days of tDCS and 6-weeks later. A 32-channel head coil was used. Metabolite levels were measured in 30×30×30 mm3 voxels in both sensorimotor cortices and the thalamus, placed anatomically (Fig 2). The sensorimotor cortices are involved in acquisition of motor skill while the thalamus has been identified as a relay center for motor function. Glutamate was quantified using a conventional PRESS sequence (TR/TE = 1800/35 ms, 64 averages with 8 unsuppressed water scans) and quantified using LC Model11 followed by CSF-tissue correction. GABA was measured using a MEGA-PRESS sequence12 (TR/TE = 1800/68 ms, 256 averages with 14 ms editing pulses applied at 1.9 ppm and 7.46 ppm alternating every two averages and 16 unsuppressed water scans) and quantified using GANNET13, including tissue correction to account for increased concentration of GABA in grey matter14. Changes in GABA and glutamate between tDCS conditions and over time were assessed using a repeated measures ANOVA analysis with age and sex covariates for each voxel and a Tukey Test was used to correct for multiple comparisons in follow-up paired analyses.
A trend toward increased glutamate was observed in the thalamus after the 5 days of intervention (p = 0.054) in the sham condition (Figure 3C). No other glutamate changes were seen.
In the left M1, increased GABA was seen between day 5 of intervention and 6 weeks follow up (p = 0.015) in the sham condition (Figure 3D). No other significant changes were detected between time points.
Study participant recruited from the University of Calgary Healthy Infants and Children's Clinical Research Program (HICCUP) and research was performed in collaboration with the Non-Invasive Neurostimulation Network (N3) of the University of Calgary.